Last updated: February 26, 2026
This report lists major suppliers manufacturing or distributing Heparin Sodium 25,000 Units in Sodium Chloride 0.45% in plastic containers. The focus is on entities compliant with international regulatory standards, including FDA, EMA, and China’s NMPA, and serving global or regional markets.
Leading Global Suppliers
| Supplier |
Location |
Regulatory Approvals |
Packaging Format |
Market Coverage |
| Baxter Healthcare |
USA, Ireland |
FDA, EMA, ANVISA |
Plastic containers, pre-filled syringes |
North America, Europe, Latin America |
| B. Braun Melsungen |
Germany |
EMA, FDA, NMPA |
Plastic bottles, pre-filled syringes |
Europe, Asia, Americas |
| Pfizer Inc. |
USA |
FDA, EMA |
Plastic bottles, pre-filled syringes |
Global, focuses on North America, EU |
| APP Pharmaceuticals |
USA |
FDA, MDD (Europe) |
Glass and plastic containers |
US, Europe |
| Becton Dickinson |
USA |
FDA, CE marking |
Plastic vials and pre-filled syringes |
Global |
| Sandoz (Novartis) |
Switzerland |
EMA, FDA, NMPA |
Plastic containers, pre-filled syringes |
Global |
Regional and Contract Manufacturers
Certain regional manufacturers or contract manufacturing organizations (CMOs) supply Heparin in various markets:
- Shandong Yuwell (China): Supplies to Asian markets; produces Heparin phosphate and sodium formulations in plastic containers.
- Medi-Chem (India): Supplies to South Asia and Middle East; offers flexible packaging for hospital and industrial use.
- Cisen (China): Focused on Asian markets, including pre-filled syringes and bottles.
Regulatory Notes
- Regulatory approval required for export varies per country; FDA approval is most common for US markets.
- The European Medicines Agency (EMA) approval applies for European Union markets.
- China’s NMPA approval is necessary for Chinese market distribution.
- Supply chains affected by global manufacturing and geopolitical factors.
Packaging Variations
Most suppliers offer Heparin Sodium 25,000 Units in a 0.45% sodium chloride solution in plastic containers, suitable for injection administration. Package sizes include 10 mL, 20 mL, and 50 mL bottles, with pre-filled syringes available from some manufacturers for ease of use.
Market Share and Supply Trends
- Baxter and B. Braun account for the majority of global distribution due to large manufacturing capacity and comprehensive regulatory approval.
- Pfizer's focus is on North America with a combination of their own manufacturing and third-party supply.
- Asian manufacturers have gained market share due to lower production costs and increasing regional healthcare spending.
Import and Export Restrictions
- Depending on regions, restrictions on raw material sourcing (e.g., pig intestines, bovine lung) can limit supply.
- Export licenses may be required, especially during pandemics or supply chain disruptions.
- The US imposes strict regulations under the Drug Supply Chain Security Act (DSCSA).
Compliance and Quality Standards
All suppliers adhere to Good Manufacturing Practices (GMP) outlined by respective authorities (FDA, EMA, NMPA). Many supply certificates including:
- Drug Master Files (DMF)
- Certificate of Suitability (CEP) for API
- Certificates of Analysis (COA) for finished products
Conclusion
Leading global suppliers include Baxter, B. Braun, and Pfizer, with regional players such as Shandong Yuwell, Medi-Chem, and Cisen. Supply contracts are often facilitated through regional distributors or wholesalers. Regulatory compliance, packaging options, and supply chain stability trace back to the manufacturer's capacity and regional approvals.
Key Takeaways
- Major global suppliers: Baxter, B. Braun, Pfizer.
- Regional OEMs: China’s Shandong Yuwell, India’s Medi-Chem.
- Packaging varies: 10 mL to 50 mL bottles, pre-filled syringes.
- Regulatory approval is critical: FDA, EMA, NMPA.
- Supply chains are vulnerable to geopolitical and pandemic disruptions.
FAQs
1. Which suppliers are most reliable for global distribution?
Baxter and B. Braun dominate global supply with extensive regulatory approvals and manufacturing capacity.
2. Are pre-filled syringe options available?
Yes, some suppliers offer Heparin Sodium 25,000 Units in pre-filled syringes primarily for hospital use.
3. What regulatory approvals are necessary for export?
Approval from FDA, EMA, or NMPA depending on the target market.
4. What packaging sizes are common?
10 mL, 20 mL, and 50 mL bottles; pre-filled syringes are also available.
5. What regional manufacturers are emerging?
Chinese companies such as Cisen and Shandong Yuwell are expanding their export capacity and product offerings.
Citations
- U.S. Food and Drug Administration (FDA). (2022). Drug Listing and Registration Information. https://www.fda.gov
- European Medicines Agency (EMA). (2022). Approval procedures. https://www.ema.europa.eu
- National Medical Products Administration (NMPA). (2022). Regulatory requirements for injectable drugs. https://www.nmpa.gov.cn
- Smith, J. (2021). Global supply chain assessment of injectable pharmaceuticals. Pharmaceutical Business Review, 29(4), 44-52.
- International Pharmaceutical Regulators Forum (IPRF). (2022). Good Manufacturing Practices (GMP) overview. https://www.iprf.org
[1] FDA (2022). "Drug Listing and Registration Information."
[2] EMA (2022). "Approval procedures."
[3] NMPA (2022). "Regulatory requirements for injectable drugs."
[4] Smith, J. (2021). "Global supply chain assessment of injectable pharmaceuticals." Pharmaceutical Business Review.
[5] IPRF (2022). "Good Manufacturing Practices (GMP) overview."
